Debut Plus

₹0.97

▼ -0.02 -2.02%

As of 28 Oct 2026 · delayed

BSE Listed

Genpharmasec Limited (531592)

Volume: 2,28,380Avg Vol 1W: 3,00,019Avg Vol 1M: 3,69,86052W Range:₹0.75₹1.8
BSE www.genpharmasec.com AI Report
Key Ratios
Checked 4h ago
Market Cap₹54 Cr
Current Price₹0.97
Previous Close₹0.99
High / Low (52w)₹1.8 / ₹0.75
Volume2,28,380
Avg Vol (1W)3,00,019
Avg Vol (1M)3,69,860
Stock P/E34.33
Book Value₹1.2
Dividend Yield0%
ROE241.95%
ROA-60.08%
Revenue (TTM)—
Revenue Growth—
Profit Margin-14.64%
Total Debt—
Shares Outstanding55 Cr
Face Value—
EPS (TTM)₹0
P/B0.81
Debt / Equity0.31
50 DMA₹1.08
200 DMA₹1.13
Day change-2.02%
Price Chart
₹0.97▼ 45.20% · 1Y
₹2₹158.0L
2025-10-28
2026-10-28

20-day avg volume: 3.8L shares

Pros
  • Healthy return on equity of 241.9%.
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 69% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹6 Cr₹8 Cr₹14 Cr₹12 Cr₹33 Cr₹40 Cr₹55 Cr₹50 Cr
EBITDA₹1 Cr₹1 Cr₹0 Cr₹1 Cr₹-1 Cr₹-1 Cr₹2 Cr₹1 Cr
Net Profit₹1 Cr₹1 Cr₹0 Cr₹1 Cr₹-1 Cr₹-1 Cr₹1 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹14 Cr₹37 Cr₹12 Cr₹32 Cr₹36 Cr₹143 Cr₹52 Cr₹45 Cr
EBITDA₹0 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹3 Cr₹2 Cr
Net Profit₹0 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr
EPS—0.03———0.01——
Balance Sheet
MetricMar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹20 Cr₹71 Cr₹80 Cr₹138 Cr
Total Liabilities₹5 Cr₹7 Cr₹15 Cr₹73 Cr
Equity₹15 Cr₹65 Cr₹65 Cr₹66 Cr
Total Debt————
Cash Flow
MetricMar 2023Mar 2024Mar 2025Mar 2026
Operating₹-3 Cr₹-3 Cr₹3 Cr₹-17 Cr
Investing₹0 Cr₹-28 Cr₹-4 Cr₹13 Cr
Financing₹3 Cr₹48 Cr₹-1 Cr₹4 Cr
Free Cash Flow₹-3 Cr₹-3 Cr₹3 Cr₹-17 Cr
Shareholding
Promoter 32.06% Institutions 0% Public 67.94%
Efficiency & Working Capital
ROCE2.2%
Interest Coverage1.8
Dividend Payout—
Debtor Days76 d
Inventory Days36 d
Payable Days82 d
Cash Conversion Cycle30 d
Working Capital Days113 d
Shareholding Details

As of 2026-09-30

Promoter32.1%
FII0%
DII0%
Institutions0%
Public67.9%
Promoter Pledge0%
No. of Shareholders99,856
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodFeb 2024Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters30%30%30%30%30%30%30%30%30%30%30%32.1%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public70%70%70%70%70%70%70%70%70%70%70%67.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,05,6931,08,1371,08,2201,05,8381,09,2061,09,0801,07,6021,05,8041,04,0211,02,2521,01,13499,856
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Sneha SadhwaniShareholding of Promoter and Promoter Group16.8%9.30 Cr
Rajesh SadhwaniShareholding of Promoter and Promoter Group15.3%8.45 Cr
Rushabh Sevantilal SanghaviPublic Shareholding3.4%1.89 Cr
Sadashiv Kanyana ShettyPublic Shareholding2.1%1.14 Cr
Vishesh Mahesh NihalaniPublic Shareholding1.5%84,00,100
L7 Hitech Private LimitedPublic Shareholding1.2%68,84,159
Narendra Chhaganlal SolankiPublic Shareholding1.1%60,09,409
Nimesh Shambhulal JoshiPublic Shareholding1%55,68,556
Board of Directors
NameDesignationYear
Mr. Sohan ChaturvediExecutive Director / Whole Time Director / CFO2025
Rajesh SadhwaniNon-Exec & Non-Independent Dir2025
Sneha SadhwaniNon-Exec & Non-Independent Dir2025
Siddhesh Shankar ShendeIndependent Non Exe. Director2025
Mayur Bharatbhai BhattIndependent Non Exe. Director2025
Sachin AphandkarIndependent Non Exe. Director2025
Hardik MakwanaCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Diagnostic Pharma Equipment₹33 Cr100%
Trading in Securities₹0 Cr0%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1565555
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-11Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202634006040
2026200103
202630005034
Insider / Designated-Person Trades

2 recent disclosure(s)

Rajesh SadhwaniAcquisition · 65,00,000
Rajesh SadhwaniAcquisition · 50,00,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Rights Issue22/02/2024 · 4,60,00,000
Company Information
Incorporated1992
AuditorAbhishek S Tiwari & Associates
Investor Email[email protected]; [email protected]
🌐 www.genpharmasec.com ↗

📍 Office 104 & 105 1st Flr, Gundecha Indl Kandivali (East), Mumbai, Maharashtra, 400101

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Vas Infrastructure Ltd.KMF Builders & Developers Ltd.Beryl Securities Ltd.Rap Corp LimitedDevine Impex Ltd.Bampsl Securities Ltd.Incon Engineers Ltd.Capri Global CapitalFDC Ltd.Gogia Capital Growth LimitedGorani Industries Ltd.KG Petrochem Ltd.All “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search